Skip to main content
Equibles

Rafferty Asset Management, LLC

Position in SLS — SELLAS Life Sciences Group, Inc.

CIK 1389426 New York, NY
Back to SLS Full portfolio

Position in SLS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,540,805
+$2,485,725 QoQ
Shares Held
239,892
-3.8% QoQ
Ownership
0.119%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#31
of 192 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rafferty Asset Management, LLC holds $335,902,097 across 164 Biotechnology names. SLS ranks #18 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 65,798 $32,683,840
2 REGN
Regeneron Pharmaceuticals, Inc.
 38,534 $24,027,490
3 ALNY
Alnylam Pharmaceuticals, Inc.
 55,332 $16,656,591
4 MRNA
Moderna, Inc.
 111,906 $7,836,777
5 INCY
Incyte Corp
 44,663 $5,062,997
6
33,369 $4,429,067
7 TWST
Twist Bioscience Corp
 40,732 $4,190,508
8 ORKA
Oruka Therapeutics, Inc.
 43,110 $4,102,778

All Filings in SLS

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,540,805 239,892
2026-03-31 $1,055,080 249,428